Pharmaceuticals and the Internet Drug Regulatory Authorities' Perspective - Joint NLN-WHI Workshop, 24-25 September 2001
(2002; 80 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoExecutive Summary
Ver el documentoOverview of activities by the World Health Organization - Dr Lembit Rägo
Ver el documentoOverview of activities by the Nordic Council on Medicines - Dr Ola Westbye
Abrir esta carpeta y ver su contenidoCountry Experiences
Ver el documentoThe Danish Consumer Council - Ms Margrethe Nielsen
Ver el documentoSwedish Industry Association - Dr Håkan Mandahl
Ver el documentoIntroduction to discussion points - Dr Lembit Rägo
Ver el documentoQuality aspects - Dr Ola Westbye
Ver el documentoPilot study on drug regulatory web sites: Current status and future challenges - Ms Elodie Jambert
Ver el documentoThe WHO model web site for drug regulatory authorities - Dr Lembit Rägo, Ms Elodie Jambert, Mr Jorg Hetzke
Ver el documentoConcluding discussion
Abrir esta carpeta y ver su contenidoAnnexes
Ver el documentoReferences
Ver el documentoBack cover
 

Back cover

The Internet is a rapidly expanding, invaluable information and communication resource. But with increasing numbers of patients and health professionals looking for medical information on the Internet, the dangers of biased information and unlawful sale of pharmaceuticals are growing fast. Many National Drug Regulatory Authorities (DRAs) are seeking to counter such problems by providing access to unbiased, good-quality drug information on their web sites.

This report of the Joint Workshop features the WHO Model Web Site for DRAs wishing to create or improve an existing web site, and a fruitful exchange of ideas that identified the minimum information an effective DRA web site should contain.

Pharmaceuticals and the Internet represents just one aspect of WHO’s contribution to drug quality assurance and safety. The three pillars of WHO’s work in this area are: developing internationally recognized norms and standards; establishing and maintaining effective drug regulation; and information support for pharmaceutical regulation.

NLN ISBN 91 8 643256 7
WHO ISBN 92 4 159006 8

Ir a la sección anterior
 

Última actualización: le 24 abril 2012